Dosidal · Belgium

Constella 290 µg

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketBelgium
Recordbe:presentation:cti:431663-01 (version 1)
Levelpresentation
Pack codenot anchored
Identifiersbe-cti-extended: 431663-01
be-authorisation: EU/1/12/801/003
eu-number: EU/1/12/801/003
Source authorityFAMHP
Read date2026-11-15T03:58:09Z
authorisation statusamp_status: AUTHORIZED
ampp_status: AUTHORIZED
commercialised_now: False
lifecycle: history
period_from: 2012-11-26
period_to: 2023-05-16
supply_problem_now: False
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
controlled status
state: unknown
identityamp_code: SAM431645-00
atc: A03A
authorisation_number: EU/1/12/801/003
cti_extended: 431663-01
form: Capsule, hard
holder: AbbVie Deutschland
medicine_type: ALLOPATHIC
name: Constella 290 µg
pack: 60
parallel_circuit: 0
parallel_import: False
substances: strength: 290.0000 ug
substance: Linaclotide
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
pack product codefmd_in_scope: True
note: no FMD product code and no CNK in SAM
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
prescription classas_published: Medical prescription - Art 6, §1 bis, 2nd paragraph, 1st indent Law 25/03/1964 + Art 61 Royal Decree 14/12/2006
class: prescription
delivery_modus: M1
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
-D75ED5-L7Xjfy5qWNlGWmPvUUimAH174FWe3YPE2lTsNYG1xi3zuYC47OdCk7bMZL2UNleBUY8ezdA7Fpuk4g
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/be:presentation:cti:431663-01 · Same medicine in other markets · Dosidal